Cited by

• Envisaging bacteria as phage targets.

  Abedon ST. Abedon ST. Bacteriophage. 2011 Jul 1;1(4):228-230. doi: 10.4161/bact.1.4.17281. Bacteriophage. 2011. PMID: 23616932 Free PMC article.
• Further Considerations on How to Improve Phage Therapy Experimentation, Practice, and Reporting: Pharmacodynamics Perspectives.

  Abedon ST. Abedon ST. Phage (New Rochelle). 2022 Jun 1;3(2):98-111. doi: 10.1089/phage.2022.0019. Epub 2022 Jun 16. Phage (New Rochelle). 2022. PMID: 36148139 Free PMC article. Review.
• Bacteriophage biocontrol in wastewater treatment.

  Jassim SA, Limoges RG, El-Cheikh H. Jassim SA, et al. World J Microbiol Biotechnol. 2016 Apr;32(4):70. doi: 10.1007/s11274-016-2028-1. Epub 2016 Mar 3. World J Microbiol Biotechnol. 2016. PMID: 26941243 Review.
• Directed in Vitro Evolution of Therapeutic Bacteriophages: The Appelmans Protocol.

  Burrowes BH, Molineux IJ, Fralick JA. Burrowes BH, et al. Viruses. 2019 Mar 11;11(3):241. doi: 10.3390/v11030241. Viruses. 2019. PMID: 30862096 Free PMC article.
• Morphologically Distinct Escherichia coli Bacteriophages Differ in Their Efficacy and Ability to Stimulate Cytokine Release In Vitro.

  Khan Mirzaei M, Haileselassie Y, Navis M, Cooper C, Sverremark-Ekström E, Nilsson AS. Khan Mirzaei M, et al. Front Microbiol. 2016 Mar 31;7:437. doi: 10.3389/fmicb.2016.00437. eCollection 2016. Front Microbiol. 2016. PMID: 27065990 Free PMC article.